Ad is loading...
CRL
Price
$187.90
Change
+$1.80 (+0.97%)
Updated
Nov 20 closing price
83 days until earnings call
TWST
Price
$41.11
Change
-$0.21 (-0.51%)
Updated
Nov 20 closing price
71 days until earnings call
Ad is loading...

CRL vs TWST

Header iconCRL vs TWST Comparison
Open Charts CRL vs TWSTBanner chart's image
Charles River Laboratories International
Price$187.90
Change+$1.80 (+0.97%)
Volume$648.1K
CapitalizationN/A
Twist Bioscience
Price$41.11
Change-$0.21 (-0.51%)
Volume$760.07K
CapitalizationN/A
CRL vs TWST Comparison Chart
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CRL vs. TWST commentary
Nov 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a StrongSell and TWST is a Sell.

COMPARISON
Comparison
Nov 21, 2024
Stock price -- (CRL: $187.90 vs. TWST: $41.11)
Brand notoriety: CRL and TWST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 83% vs. TWST: 104%
Market capitalization -- CRL: $13.96B vs. TWST: $1.98B
CRL [@Medical Specialties] is valued at $13.96B. TWST’s [@Medical Specialties] market capitalization is $1.98B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 0 FA rating(s) are green whileTWST’s FA Score has 0 green FA rating(s).

  • CRL’s FA Score: 0 green, 5 red.
  • TWST’s FA Score: 0 green, 5 red.
According to our system of comparison, CRL is a better buy in the long-term than TWST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 3 TA indicator(s) are bullish while TWST’s TA Score has 4 bullish TA indicator(s).

  • CRL’s TA Score: 3 bullish, 7 bearish.
  • TWST’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TWST is a better buy in the short-term than CRL.

Price Growth

CRL (@Medical Specialties) experienced а -9.02% price change this week, while TWST (@Medical Specialties) price change was -3.25% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.45%. For the same industry, the average monthly price growth was -2.79%, and the average quarterly price growth was -3.75%.

Reported Earning Dates

CRL is expected to report earnings on Feb 12, 2025.

TWST is expected to report earnings on Jan 31, 2025.

Industries' Descriptions

@Medical Specialties (-4.45% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($14B) has a higher market cap than TWST($1.98B). TWST YTD gains are higher at: 11.530 vs. CRL (-20.516). CRL has higher annual earnings (EBITDA): 1.03B vs. TWST (-172.41M). TWST has more cash in the bank: 311M vs. CRL (277M). TWST has less debt than CRL: TWST (91.9M) vs CRL (3.07B). CRL has higher revenues than TWST: CRL (4.13B) vs TWST (262M).
CRLTWSTCRL / TWST
Capitalization14B1.98B706%
EBITDA1.03B-172.41M-599%
Gain YTD-20.51611.530-178%
P/E Ratio29.15N/A-
Revenue4.13B262M1,576%
Total Cash277M311M89%
Total Debt3.07B91.9M3,336%
FUNDAMENTALS RATINGS
CRL vs TWST: Fundamental Ratings
CRL
TWST
OUTLOOK RATING
1..100
5964
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
47
Fair valued
PROFIT vs RISK RATING
1..100
7888
SMR RATING
1..100
6397
PRICE GROWTH RATING
1..100
6153
P/E GROWTH RATING
1..100
50100
SEASONALITY SCORE
1..100
2050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (47) in the Biotechnology industry is in the same range as CRL (77) in the Miscellaneous Commercial Services industry. This means that TWST’s stock grew similarly to CRL’s over the last 12 months.

CRL's Profit vs Risk Rating (78) in the Miscellaneous Commercial Services industry is in the same range as TWST (88) in the Biotechnology industry. This means that CRL’s stock grew similarly to TWST’s over the last 12 months.

CRL's SMR Rating (63) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for TWST (97) in the Biotechnology industry. This means that CRL’s stock grew somewhat faster than TWST’s over the last 12 months.

TWST's Price Growth Rating (53) in the Biotechnology industry is in the same range as CRL (61) in the Miscellaneous Commercial Services industry. This means that TWST’s stock grew similarly to CRL’s over the last 12 months.

CRL's P/E Growth Rating (50) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for TWST (100) in the Biotechnology industry. This means that CRL’s stock grew somewhat faster than TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLTWST
RSI
ODDS (%)
Bearish Trend 1 day ago
65%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 11 days ago
72%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
59%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
CRL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PABWX18.690.05
+0.27%
Principal MidCap Value I R4
HNACX123.830.01
+0.01%
Harbor Capital Appreciation Retirement
HGHFX41.32N/A
N/A
Hartford Healthcare F
IMACX9.55-0.01
-0.10%
Delaware Ivy Multi-Asset Income C
CSDRX13.94-0.03
-0.21%
Columbia Global Opportunities Adv

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
+0.97%
IQV - CRL
73%
Closely correlated
+1.59%
CTKB - CRL
61%
Loosely correlated
N/A
AZTA - CRL
58%
Loosely correlated
+9.14%
RGEN - CRL
56%
Loosely correlated
+8.10%
MEDP - CRL
55%
Loosely correlated
+3.53%
More

TWST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TWST has been loosely correlated with MASS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TWST jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TWST
1D Price
Change %
TWST100%
-0.51%
MASS - TWST
48%
Loosely correlated
+3.23%
VCYT - TWST
46%
Loosely correlated
+0.13%
AZTA - TWST
46%
Loosely correlated
+9.14%
ALGN - TWST
46%
Loosely correlated
+0.58%
CRL - TWST
45%
Loosely correlated
+0.97%
More